Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dienogest - Bayer HealthCare Pharmaceuticals/Mochida Pharmaceutical

Next Previous
Drug Profile

Dienogest - Bayer HealthCare Pharmaceuticals/Mochida Pharmaceutical

Alternative Names: Visanne; BAY 865258; Dinagest; Endometrion®; M 18575; MJR-35; SH T00660AA; STS 557; Visanne

Latest Information Update: 12 Feb 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer Schering Pharma
  • Developer Bayer HealthCare Pharmaceuticals; Mochida Pharmaceutical
  • Class Estrenes; Hormonal replacements; Oral contraceptives; Small molecules; Steroids; Testosterone congeners
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Endometriosis; Menopausal syndrome; Pregnancy
  • Preregistration Dysmenorrhoea
  • Phase III Adenomyosis

Most Recent Events

  • 08 Feb 2019 Preregistration for Dysmenorrhoea in Japan (PO)
  • 20 Dec 2018 Registered for Endometriosis in China (PO)
  • 24 Jun 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top